← Leaderboards
Karen L Teff
University Of Pennsylvania
$6,704,560
Attributed
$6,704,560
Total exposure
14
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $969.6K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$6,704,560 · 14
By mechanism
R01$2,884,707 · 2
M01$1,602,509 · 8
P01$1,432,588 · 1
R21$784,756 · 2
P60$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Robert J. Lee$5,266,158
- Joel Martin Kaplan$1,055,835
- Michael Aaron Kohanski$832,432
- J. Kevin Kevin Foskett$22,784,994
- John R. Monterosso$3,978,747
Others in their field
Top investigators on “Insulin”
- Jeffrey P Krischer · University Of South Florida$605,714,892
- John M Lachin · George Washington University$153,440,346
- David M Nathan · Massachusetts Institute Of Technology$139,041,931
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Mark A Magnuson · Vanderbilt University$79,749,111
- Jose A Luchsinger · Columbia University Health Sciences$71,267,462
Research focus
InsulinHuman SubjectClinical ResearchObesityGlucosePancreatic Islet FunctionNutrition Related TagGlucose MetabolismAtropineDiabetes MellitusHormone Regulation /Control MechanismHyperinsulinismLaboratoriesBlood GlucoseFutureInsulin ResistanceParasympathetic Nervous SystemTriglyceridesNutrient Intake ActivityBlood Glucose RegulationFundingLeptinHyperglycemiaNeuroendocrine System
Grant awards (44)
Biomarker Core$282,948
P01 · FY2013 · HL · contact PI
Atypical Antipsychotics: Effects on Hepatic Glucose and Lipid Metabolism in Human$290,249
R01 · FY2012 · DK · contact PI
Biomarker Core$286,873
P01 · FY2012 · HL · contact PI
Sweet taste receptors and glucose metabolism in healthy and T2DM humans$184,182
R21 · FY2012 · DK · contact PI
Atypical Antipsychotics: Effects on Hepatic Glucose and Lipid Metabolism in Human$434,843
R01 · FY2011 · DK · contact PI
Biomarker Core$286,873
P01 · FY2011 · HL · contact PI
Sweet taste receptors and glucose metabolism in healthy and T2DM humans$207,458
R21 · FY2011 · DK · contact PI
Atypical Antipsychotics: Effects on Hepatic Glucose and Lipid Metabolism in Human$472,070
R01 · FY2010 · DK · contact PI
Biomarker Core$286,873
P01 · FY2010 · HL · contact PI
Atypical Antipsychotics: Effects on Hepatic Glucose and Lipid Metabolism in Human$495,390
R01 · FY2009 · DK · contact PI
Biomarker Core$289,021
P01 · FY2009 · HL · contact PI
The Cholinergic Anti-Inflammatory Pathway in Human Obesity and Insulin Resistance$185,216
R21 · FY2009 · DK · contact PI
The Cholinergic Anti-Inflammatory Pathway in Human Obesity and Insulin Resistance$207,900
R21 · FY2008 · DK · contact PI
EFFECT OF FRUCTOSE AND GLUCOSE ON LEPTIN, GHRELIN AND TRIGLYCERIDES$33,064
M01 · FY2005 · RR
MENSTRUAL CYCLE EFFECTS ON INSULIN SENSITIVITY IN TYPE 1 DIABETIC WOMEN$33,064
M01 · FY2005 · RR
EFFECT OF PROLONGED MILD HYPERGLYCEMIA ON THE NEURAL$7,158
M01 · FY2005 · RR
EFFECT OF HYPERGLYCEMIA ON AUTONOMIC ACTIVITY$3,068
M01 · FY2005 · RR
Prolonged Mild Hyperglycemia on the Neural Contribution to Insulin &Degradation$82,384
M01 · FY2004 · RR
Effect of Fructose and Glucose on Leptin, Ghrelin and Triglycerides$53,620
M01 · FY2004 · RR
Effect of Hyperglycemia on Autonomic Activity$29,118
M01 · FY2004 · RR
Menstrual Cycle Effects on Insulin Sensitivity in Type 1 Diabetic Women$13,849
M01 · FY2004 · RR
VAGAL CONTROL OF INSULIN RELEASE IN HUMANS$309,040
R01 · FY2003 · DK
VAGAL CONTROL OF INSULIN RELEASE IN HUMANS$301,562
R01 · FY2002 · DK
VAGALLY MEDIATED INSULIN RELEASE AFTER PROLONGED HYPERGLYCEMIA$124,146
M01 · FY2002 · RR
INHIBITION OF PARASYMPATHETIC ACTIVITY--EFFECT ON INSULIN RELEASE$124,146
M01 · FY2002 · RR
Taste, hunger, satiety &weight in black American women$0
P60 · FY2002 · MD
VAGAL CONTROL OF INSULIN RELEASE IN HUMANS$294,301
R01 · FY2001 · DK
VAGALLY MEDIATED INSULIN RELEASE AFTER PROLONGED HYPERGLYCEMIA$124,146
M01 · FY2001 · RR
INHIBITION OF PARASYMPATHETIC ACTIVITY--EFFECT ON INSULIN RELEASE$124,146
M01 · FY2001 · RR
VAGALLY MEDIATED INSULIN RELEASE AFTER PROLONGED HYPERGLYCEMIA$0
M01 · FY2001 · RR
INHIBITION OF PARASYMPATHETIC ACTIVITY--EFFECT ON INSULIN RELEASE$0
M01 · FY2001 · RR
VAGAL CONTROL OF INSULIN RELEASE IN HUMANS$287,252
R01 · FY2000 · DK
EFFECTS OF VARYING DIETARY MACRONUTRIENTS ON PLASMA LEPTIN IN WOMEN$187,536
M01 · FY2000 · RR
EFFECTS OF VARYING DIETARY MACRONUTRIENTS ON PLASMA LEPTIN IN WOMEN$187,536
M01 · FY2000 · RR
INDICES OF ACTIVITY OF THE PARASYMPATHETIC NERVOUS SYSTEM$187,536
M01 · FY2000 · RR
INDICES OF ACTIVITY OF THE PARASYMPATHETIC NERVOUS SYSTEM$187,536
M01 · FY2000 · RR
INHIBITION OF PARASYMPATHETIC ACTIVITY--EFFECT ON INSULIN RELEASE$25,114
M01 · FY2000 · RR
VAGALLY MEDIATED INSULIN RELEASE AFTER PROLONGED HYPERGLYCEMIA$25,114
M01 · FY2000 · RR
EFFECTS OF VARYING DIETARY MACRONUTRIENTS ON PLASMA LEPTIN IN WOMEN$25,114
M01 · FY2000 · RR
INDICES OF ACTIVITY OF THE PARASYMPATHETIC NERVOUS SYSTEM$25,114
M01 · FY2000 · RR
VAGALLY MEDIATED INSULIN RELEASE AFTER PROLONGED HYPERGLYCEMIA$0
M01 · FY2000 · RR
INHIBITION OF PARASYMPATHETIC ACTIVITY--EFFECT ON INSULIN RELEASE$0
M01 · FY2000 · RR
INHIBITION OF PARASYMPATHETIC ACTIVITY--EFFECT ON INSULIN RELEASE$0
M01 · FY2000 · RR
VAGALLY MEDIATED INSULIN RELEASE AFTER PROLONGED HYPERGLYCEMIA$0
M01 · FY2000 · RR